• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西首都新冠病毒的实验室准备情况及基因组监测

Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil.

作者信息

Cavalcante Fabrício Vieira, Martin Christina Pacheco Santos, Frio Gustavo Saraiva, Stabeli Rodrigo Guerino, Santos Leonor Maria Pacheco

机构信息

Universidade de Brasília, Brasília, Brasil.

Universidade Federal da Paraíba (UFPB), João Pessoa, Brasil.

出版信息

PLOS Glob Public Health. 2025 Jan 9;5(1):e0003289. doi: 10.1371/journal.pgph.0003289. eCollection 2025.

DOI:10.1371/journal.pgph.0003289
PMID:39787152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11717220/
Abstract

This study aims to analyze the diagnostic readiness to Covid-19 and the genomic surveillance of SARS-CoV-2 in Brasília, the capital of Brazil. This is a retrospective, cross-sectional study, with data from: cases/deaths-Ministry of Health; RT-PCR analyses Brasília Central Public Health Laboratory (LACEN); genomics-Global Initiative on Sharing All Influenza Data (GISAID). It was found that in March 2021, with the Gamma variant was predominant, RT-PCR diagnostic tests administered by LACEN reached their peak, followed by a reduction, possibly due to the start of vaccination. New peaks were observed in September 2021 and January 2022. The average time for releasing RT-PCR results was reduced from eight days (July 2020), to around eight hours in 2023. The participation of private laboratories was evident in sequencing the SARS-CoV-2 variants of concern in Brasília (n = 1,897). LACEN sequenced 50% of the samples received (571). A decrease in the incidence of cases and deaths due to Covid-19 was noted in the years 2022 to 2023, following the national trend. LACEN maintained RT-PCR diagnostic tests administered satisfactorily throughout the period. Regarding the genomic surveillance of SARS-CoV-2, the vast majority of samples were sequenced by private laboratories when compared to the public laboratory.

摘要

本研究旨在分析巴西首都巴西利亚对新冠病毒的诊断准备情况以及新冠病毒的基因组监测情况。这是一项回顾性横断面研究,数据来自:病例/死亡数据——卫生部;逆转录聚合酶链反应(RT-PCR)分析——巴西利亚中央公共卫生实验室(LACEN);基因组学——全球共享流感数据倡议组织(GISAID)。研究发现,2021年3月,随着伽马变异株占主导地位,LACEN进行的RT-PCR诊断检测达到峰值,随后下降,这可能是由于疫苗接种开始。2021年9月和2022年1月出现了新的峰值。RT-PCR结果发布的平均时间从2020年7月的八天减少到2023年的约八小时。在巴西利亚对新冠病毒变异株进行测序时,私立实验室的参与很明显(n = 1897)。LACEN对收到的样本中的50%(571份)进行了测序。2022年至2023年,随着全国趋势,新冠病毒导致的病例和死亡发生率有所下降。LACEN在此期间一直令人满意地进行RT-PCR诊断检测。关于新冠病毒的基因组监测,与公共实验室相比,绝大多数样本是由私立实验室测序的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c376/11717220/a8b9dee64eb3/pgph.0003289.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c376/11717220/4d5e52abc2b5/pgph.0003289.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c376/11717220/911f2dc094ef/pgph.0003289.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c376/11717220/e1d0f939cf81/pgph.0003289.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c376/11717220/a8b9dee64eb3/pgph.0003289.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c376/11717220/4d5e52abc2b5/pgph.0003289.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c376/11717220/911f2dc094ef/pgph.0003289.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c376/11717220/e1d0f939cf81/pgph.0003289.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c376/11717220/a8b9dee64eb3/pgph.0003289.g004.jpg

相似文献

1
Laboratory readiness and genomic surveillance of Covid-19 in the capital of Brazil.巴西首都新冠病毒的实验室准备情况及基因组监测
PLOS Glob Public Health. 2025 Jan 9;5(1):e0003289. doi: 10.1371/journal.pgph.0003289. eCollection 2025.
2
SARS-CoV-2 laboratory surveillance during the first year of the COVID-19 pandemic in southern Brazil.巴西南部 COVID-19 大流行第一年的 SARS-CoV-2 实验室监测。
Rev Soc Bras Med Trop. 2023 Jan 23;56. doi: 10.1590/0037-8682-0146-2022. eCollection 2023.
3
Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program.使用病毒测序对疾病预防控制中心基因组监测计划进行 SARS-CoV-2 变异体的鉴定。
BMC Infect Dis. 2022 Apr 25;22(1):404. doi: 10.1186/s12879-022-07374-7.
4
Surveillance Metrics and History of the COVID-19 Pandemic in Central Asia: Updated Epidemiological Assessment.中亚地区 COVID-19 大流行的监测指标和历史:更新的流行病学评估。
JMIR Public Health Surveill. 2024 Aug 28;10:e52318. doi: 10.2196/52318.
5
Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants.精准健康诊断和监测网络使用 S 基因靶标失败 (SGTF) 与测序技术相结合,来追踪新兴的 SARS-CoV-2 变异株。
Immun Inflamm Dis. 2022 Jun;10(6):e634. doi: 10.1002/iid3.634.
6
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.关注的紧急 SARS-CoV-2 变异株:用于快速检测和监测的新型多重实时 RT-PCR 检测方法。
Microbiol Spectr. 2022 Feb 23;10(1):e0251321. doi: 10.1128/spectrum.02513-21.
7
Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in Canada: Longitudinal Trend Analysis.加拿大2019冠状病毒病大流行(2020 - 2023年)的最新监测指标与历史:纵向趋势分析
JMIR Public Health Surveill. 2024 Dec 5;10:e53218. doi: 10.2196/53218.
8
Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak.巴西南部 2021 年疫情后出现的类似 Γ 型-II 和 Γ-S:E661D SARS-CoV-2 谱系的再次出现。
Virol J. 2021 Nov 17;18(1):222. doi: 10.1186/s12985-021-01690-1.
9
Systematic Genomic Surveillance of SARS-CoV-2 Virus on Illumina Sequencing Platforms in the Slovak Republic-One Year Experience.斯洛伐克共和国 Illumina 测序平台上的 SARS-CoV-2 病毒的系统基因组监测-一年经验。
Viruses. 2022 Nov 2;14(11):2432. doi: 10.3390/v14112432.
10
Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study.严重急性呼吸综合征冠状病毒2奥密克戎(BA.1)变异株在非洲的出现与传播:一项观察性研究
Lancet Glob Health. 2025 Feb;13(2):e256-e267. doi: 10.1016/S2214-109X(24)00419-4.

本文引用的文献

1
Role of Portuguese community pharmacy and pharmacists in self-care.葡萄牙社区药房及药剂师在自我护理中的作用。
Explor Res Clin Soc Pharm. 2023 Sep 21;12:100334. doi: 10.1016/j.rcsop.2023.100334. eCollection 2023 Dec.
2
The Omicron Lineages BA.1 and BA.2 ( SARS-CoV-2) Have Repeatedly Entered Brazil through a Single Dispersal Hub.奥密克戎变异株 BA.1 和 BA.2(SARS-CoV-2)通过单个传播中心多次进入巴西。
Viruses. 2023 Mar 30;15(4):888. doi: 10.3390/v15040888.
3
Implementation of genomic surveillance of SARS-CoV-2 in the Caribbean: Lessons learned for sustainability in resource-limited settings.
加勒比地区新冠病毒基因组监测的实施:资源有限环境下可持续性的经验教训
PLOS Glob Public Health. 2023 Feb 22;3(2):e0001455. doi: 10.1371/journal.pgph.0001455. eCollection 2023.
4
Covid-19: temporal evolution and immunization in the three epidemiological waves, Brazil, 2020-2022.Covid-19:2020-2022 年巴西三次流行病学浪潮中的时间演变和免疫
Rev Saude Publica. 2022 Dec 9;56:105. doi: 10.11606/s1518-8787.2022056004907. eCollection 2022.
5
Genomic Epidemiology of SARS-CoV-2 in Tocantins State and the Diffusion of P.1.7 and AY.99.2 Lineages in Brazil.巴西托坎廷斯州 SARS-CoV-2 的基因组流行病学与 P.1.7 和 AY.99.2 谱系的传播
Viruses. 2022 Mar 23;14(4):659. doi: 10.3390/v14040659.
6
High Rate of Mutational Events in SARS-CoV-2 Genomes across Brazilian Geographical Regions, February 2020 to June 2021.2020 年 2 月至 2021 年 6 月期间,巴西各地 SARS-CoV-2 基因组中的突变事件发生率较高。
Viruses. 2021 Sep 10;13(9):1806. doi: 10.3390/v13091806.
7
COVID-19 laboratory preparedness and response in the Americas Region: Lessons learned.美洲区域应对 COVID-19 的实验室准备工作:经验教训。
PLoS One. 2021 Jun 29;16(6):e0253334. doi: 10.1371/journal.pone.0253334. eCollection 2021.
8
Direct from the COVID-19 crisis: research and innovation sparks in Brazil.直面新冠疫情危机:巴西的研究与创新火花。
Health Res Policy Syst. 2021 Jan 21;19(1):10. doi: 10.1186/s12961-020-00674-x.
9
Time interval between onset of symptoms and COVID-19 testing in Brazilian state capitals, August 2020.2020年8月巴西各首府城市症状出现与新冠病毒检测之间的时间间隔。
Epidemiol Serv Saude. 2020 Dec 18;30(1):e2020788. doi: 10.1590/S1679-4974202100010002. eCollection 2020.
10
FIP's response to the COVID-19 pandemic: Global pharmacy rises to the challenge.FIP 应对 COVID-19 大流行的举措:全球药剂师迎难而上。
Res Social Adm Pharm. 2021 Jan;17(1):1929-1933. doi: 10.1016/j.sapharm.2020.07.004. Epub 2020 Jul 10.